Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R12618 DNC-D | ||
| By: Campbell, Menéndez | S.B. No. 1812 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to prior authorization for prescription drug benefits | |
| related to the treatment of neurodegenerative diseases. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. The heading to Subchapter N, Chapter 1369, | |
| Insurance Code, is amended to read as follows: | |
| SUBCHAPTER N. COVERAGE OF PRESCRIPTION DRUGS FOR CERTAIN | |
| [ |
|
| SECTION 2. Section 1369.654(a), Insurance Code, is amended | |
| to read as follows: | |
| (a) A health benefit plan issuer that provides prescription | |
| drug benefits may not require an enrollee to receive more than one | |
| prior authorization annually of the prescription drug benefit for a | |
| prescription drug prescribed to treat an autoimmune disease, | |
| hemophilia, a neurodegenerative disease, or Von Willebrand | |
| disease. | |
| SECTION 3. The change in law made by this Act applies only | |
| to a health benefit plan that is delivered, issued for delivery, or | |
| renewed on or after January 1, 2026. A health benefit plan | |
| delivered, issued for delivery, or renewed before January 1, 2026, | |
| is governed by the law as it existed immediately before the | |
| effective date of this Act, and that law is continued in effect for | |
| that purpose. | |
| SECTION 4. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.